Z-0412-2020 Class II Terminated
FDA device recall Z-0412-2020 was initiated by Randox Laboratories, Limited on Oct 4, 2019 and is designated Class II. Reason for recall: Removal of claims for N-proBNP in the Liquid Cardiac Control model numbers CQ5051 due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots. The recall status is terminated (terminated Jul 6, 2020). Affected quantity: 6,208.
Recall details
- Product Type
- Devices
- Report Date
- Nov 27, 2019
- Initiation Date
- Oct 4, 2019
- Termination Date
- Jul 6, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,208
Product description
Reason for recall
Distribution pattern
US Distribution: WV, CA, DE, NJ, NY, GA, IN, PR OUS Distribution: CA, PL, CH, JP, NL, IT, CN, GB, IE, RU, MD, BY, SA, VN, AE, BH, DK, CO, ES, FR, TW, PH, TH, OM, HU, IN, KR, ZA, AU, CZ, PE, CL, IR, NZ, BE, DE, BA, SV, SK, HK, PT, PK, BR, TR, UA, SE, QA, LT, PE,
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0412-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026